Cargando…
First Trimester Aneuploidy Screening Markers in Women with Pre-Gestational Diabetes Mellitus
Objective: To investigate whether maternal serum pregnancy associated plasma protein-A (PAPP-A), total β human chorionic gonadotropin (hCG) levels and nuchal translucency (NT) measurements differ in women with pre-gestational diabetes mellitus (PGDM) compared to non-diabetic controls and to assess w...
Autores principales: | Gurram, Padmalatha, Benn, Peter, Grady, James, Prabulos, Anne-Marie, Campbell, Winston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449679/ https://www.ncbi.nlm.nih.gov/pubmed/26237386 http://dx.doi.org/10.3390/jcm3020480 |
Ejemplares similares
-
First trimester diagnosis and screening for fetal aneuploidy
por: Driscoll, Deborah A., et al.
Publicado: (2008) -
The effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency in women with threatened miscarriage
por: Yıldız, Elif, et al.
Publicado: (2023) -
First-Trimester Screening for Gestational Diabetes Mellitus in Twin Pregnancies
por: Buerger, Olga, et al.
Publicado: (2021) -
The effect of a vanishing twin on first- and second-trimester maternal serum markers and ultrasound screening for aneuploidy
por: Lee, Da Rae, et al.
Publicado: (2023) -
Can Thyroid Screening in the First Trimester Improve the Prediction of Gestational Diabetes Mellitus?
por: Milovanović, Zagorka, et al.
Publicado: (2022)